Industry headlines are constantly buzzing with M&A activity and Healthtech VC investment trends.
This week on Diagnosing Healthtech, Jeff Englander (Healthcare Strategist) and Redox’s Sarah Bottjen (Director of Sales Enablement) will delve into these topics in an interview with HSBC Innovation Banking’s Chris Moniz.
In addition to his role as Managing Director, Chris is a contributing author to HSBC Innovation Banking’s 1H 2023 Venture Healthcare Report, which combines analytics and expertise to provide industry perspectives and actionable insight to companies and investors.
